- Report
- August 2020
- 34 Pages
China
From €2886EUR$2,995USD£2,482GBP
- Report
- August 2020
- 34 Pages
South Korea
From €2886EUR$2,995USD£2,482GBP
- Report
- August 2020
- 34 Pages
Russia
From €2886EUR$2,995USD£2,482GBP
- Report
- August 2020
- 34 Pages
Spain
From €2886EUR$2,995USD£2,482GBP
- Report
- August 2020
- 34 Pages
Italy
From €2886EUR$2,995USD£2,482GBP
- Report
- August 2020
- 34 Pages
France
From €2886EUR$2,995USD£2,482GBP
- Report
- August 2020
- 34 Pages
United Kingdom
From €2886EUR$2,995USD£2,482GBP
- Report
- August 2020
- 34 Pages
Brazil
From €2886EUR$2,995USD£2,482GBP
- Report
- August 2020
- 34 Pages
Mexico
From €2886EUR$2,995USD£2,482GBP
The Prostate Biopsy market is a subset of the larger Surgical Procedures market. It involves the removal of tissue samples from the prostate gland for diagnostic purposes. The procedure is typically performed using a transrectal ultrasound-guided biopsy, which is a minimally invasive procedure. The biopsy is used to diagnose prostate cancer, as well as other conditions such as prostatitis and benign prostatic hyperplasia.
The Prostate Biopsy market is highly competitive, with a variety of companies offering products and services. These include medical device manufacturers, such as Olympus, Stryker, and Cook Medical, as well as biopsy services providers, such as Urovant Sciences and UroGen Pharma. Additionally, there are a number of healthcare providers that offer prostate biopsy services, such as hospitals, clinics, and private practices. Show Less Read more